A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

NCT07015697 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Solid Tumors

Interventions

DRUG: Trastuzumab Deruxtecan

Sponsor

Daiichi Sankyo

Collaborators

[object Object]